quinoxalines has been researched along with Choroid Neovascularization in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, J; Durairaj, C; Lin, T; Liu, Y; Shen, J | 1 |
| Bai, Y; Gil, DW; Kusari, J; Le, YZ; Padillo, E; Song, Z; Wang, J; Zhou, SX; Zhu, M | 1 |
| Assia, EI; Belkin, M; Ferencz, JR; Gilady, G; Harel, O | 1 |
1 trial(s) available for quinoxalines and Choroid Neovascularization
| Article | Year |
|---|---|
Topical brimonidine reduces collateral damage caused by laser photocoagulation for choroidal neovascularization.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Choroidal Neovascularization; Double-Blind Method; Female; Humans; Laser Coagulation; Male; Neuroprotective Agents; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Quinoxalines; Retinal Diseases; Visual Acuity | 2005 |
2 other study(ies) available for quinoxalines and Choroid Neovascularization
| Article | Year |
|---|---|
Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Aqueous Humor; Biological Availability; Blood-Retinal Barrier; Brimonidine Tartrate; Capillary Permeability; Choroid; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Dexamethasone; Female; Glucocorticoids; Intravitreal Injections; Macaca fascicularis; Models, Animal; Quinoxalines; Rabbits; Retina; Tandem Mass Spectrometry; Vitreous Body | 2014 |
Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Fluorescein Angiography; Humans; Immunoblotting; Infant, Newborn; Intravitreal Injections; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Oxygen; Quinoxalines; Rabbits; Rats; Rats, Inbred BN; Retinal Neovascularization; Retinopathy of Prematurity; Time Factors | 2011 |